Current through Register Vol. 51, No. 19, September 20, 2024
A. Each fiscal year
the CCPC shall determine:
(1) The amount of
money available for grants under the Maryland Cancer Fund;
(2) The allocation of funding for cancer:
(i) Research;
(ii) Primary prevention;
(iii) Secondary prevention; and
(iv) Treatment; and
(3) The maximum grant award amount for each
type of grant.
B. Each
year the Department shall consider for award, funding for one or more of the
following types of grant applications for cancer:
(1) Research;
(2) Primary prevention;
(3) Secondary prevention; and
(4) Treatment.
C. The CCPC shall develop one or more
evaluation committees or shall contract with one or more external consultants
with expertise in cancer research and prevention to review the cancer research
and primary prevention and secondary prevention grant applications that are
submitted for funding under the Maryland Cancer Fund.
D. Due to the need for timeliness in the
cancer treatment grants, the CCPC shall review each application for cancer
treatment.
E. The evaluation
committee or external consultants shall review:
(1) Cancer research grant applications based
on:
(a) Scientific need;
(b) The degree to which the cancer research
plan will achieve the goals and objectives set forth in the plan;
(c) The inclusion of a plan for Institutional
Review Board approval;
(d) The
feasibility of the timeline in delivering goals and objectives of the
plan;
(e) The experience and
expertise of the principal investigator;
(f) The degree to which a grant application
addresses eliminating disparities between racial and ethnic minorities and the
white population;
(g) Whether the
research is recommended in the Maryland Comprehensive Cancer Plan;
(h) The lack of other resources or funding
for the proposed research; and
(i)
The amount of the funding requested;
(2) Cancer primary prevention grant
applications based on:
(a) The need for the
cancer primary prevention activity;
(b) The previously documented effectiveness
of the primary prevention intervention;
(c) The degree to which the cancer primary
prevention plan will achieve the goals and objectives set forth in the
plan;
(d) The degree to which a
grant application addresses eliminating disparities between racial and ethnic
minorities and the white population;
(e) The experience of the applicant in cancer
primary prevention;
(f) Whether the
primary prevention intervention is recommended in the Maryland Comprehensive
Cancer Control Plan;
(g) The lack
of other resources or funding for the proposal; and
(h) The amount of funding requested;
and
(3) Cancer secondary
prevention grant applications based on:
(a)
The previously documented effectiveness of the secondary prevention
intervention;
(b) The need for the
cancer secondary prevention intervention in the population group to be
served;
(c) The degree to which the
cancer secondary prevention plan will achieve the goals and objectives of the
plan;
(d) The feasibility of the
timeline in delivering the goals and objectives of the plan;
(e) The extent to which medical guidelines
for screening and diagnosis are being followed;
(f) The percent of the budget allocated to
clinical services;
(g) The degree
to which the grant application addresses eliminating disparities between racial
and ethnic minorities and the white population;
(h) The experience of the applicant in cancer
secondary prevention;
(i) Whether
the secondary prevention intervention is recommended in the Maryland
Comprehensive Cancer Control Plan;
(j) The lack of other resources or funding
for the proposal; and
(k) The
amount requested.
F. After reviewing each cancer research,
primary prevention, and secondary prevention grant application, the evaluation
committee or external consultant shall make a recommendation to the CCPC about
whether to award grant funds to each applicant.
G. The CCPC shall review each cancer
treatment application based on:
(1)
Completeness;
(2) Availability of
funds; and
(3) Whether the
application meets the relevant application process requirements set forth in
this chapter.
H. The
Director of the CCPC shall recommend an application to the Secretary for
approval based upon:
(1) The evaluation
committee's or external consultant's recommendations for awarding the cancer
research, primary prevention, secondary prevention, and treatment grants for
each application; and
(2) The
availability of funds.
I. The Secretary shall:
(1) Consider the grant recommendations of the
CCPC for the cancer:
(a) Research;
(b) Primary prevention;
(c) Secondary prevention; and
(d) Treatment; and
(2) Make the final determination on which
grant applications to approve.
J. A grant period expires 1 year from the
date of award of the grant, unless extended as set forth in Regulation .16 of
this chapter.
K. A person awarded a
grant under this chapter may apply for a no-cost extension of the grant period
for the award before the expiration of the grant period, as set forth in
§J of this regulation, by submitting a written request for an extension to
the CCPC.
L. In evaluating whether
to grant an extension of the grant period, the CCPC:
(1) Shall assess whether progress has been
made on the grant; and
(2) If
progress has been made based on the reports submitted pursuant to Regulation
.16C of this chapter, may recommend to the Secretary that an extension be
granted.
M. The
Secretary may approve an extension for up to 1 year based on:
(1) The recommendation of the CCPC;
and
(2) Whether progress has been
shown on the grant pursuant to Regulation .16C of this chapter.
